CRIS Current Research Information System

BRANDI, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.058
EU - Europa 8.344
AS - Asia 5.008
AF - Africa 521
SA - Sud America 40
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 8
Totale 25.989
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.013
GB - Regno Unito 2.180
CN - Cina 1.674
SG - Singapore 1.305
IT - Italia 1.244
SE - Svezia 1.211
VN - Vietnam 1.206
DE - Germania 1.081
IE - Irlanda 550
IN - India 524
CH - Svizzera 455
RU - Federazione Russa 361
UA - Ucraina 320
FR - Francia 287
TG - Togo 178
ZA - Sudafrica 177
EE - Estonia 160
FI - Finlandia 147
JO - Giordania 96
BG - Bulgaria 87
CI - Costa d'Avorio 80
ID - Indonesia 62
BE - Belgio 49
NG - Nigeria 45
AT - Austria 43
CA - Canada 43
GR - Grecia 31
NL - Olanda 29
SC - Seychelles 25
JP - Giappone 23
IR - Iran 22
HR - Croazia 20
PL - Polonia 18
BR - Brasile 16
CL - Cile 16
RO - Romania 16
TR - Turchia 14
KR - Corea 13
ES - Italia 12
HK - Hong Kong 12
LB - Libano 10
LT - Lituania 9
UZ - Uzbekistan 9
PS - Palestinian Territory 8
AU - Australia 7
CZ - Repubblica Ceca 7
PT - Portogallo 7
A2 - ???statistics.table.value.countryCode.A2??? 6
MY - Malesia 6
TN - Tunisia 5
DK - Danimarca 4
EC - Ecuador 4
HU - Ungheria 4
PH - Filippine 4
AE - Emirati Arabi Uniti 3
DZ - Algeria 3
NZ - Nuova Zelanda 3
SA - Arabia Saudita 3
SK - Slovacchia (Repubblica Slovacca) 3
TW - Taiwan 3
AR - Argentina 2
BD - Bangladesh 2
EG - Egitto 2
EU - Europa 2
GH - Ghana 2
MX - Messico 2
PK - Pakistan 2
RS - Serbia 2
SI - Slovenia 2
UG - Uganda 2
IL - Israele 1
IQ - Iraq 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MA - Marocco 1
MC - Monaco 1
MD - Moldavia 1
MU - Mauritius 1
NO - Norvegia 1
PE - Perù 1
SM - San Marino 1
TH - Thailandia 1
VE - Venezuela 1
Totale 25.989
Salva come PNG Salva come JPEG
Città #
Southend 1.998
Chandler 1.329
Fairfield 1.286
Singapore 1.160
Dong Ket 832
Ashburn 809
Santa Clara 664
Princeton 634
Wilmington 597
Houston 590
Woodbridge 578
Seattle 529
Dublin 500
Bern 438
Cambridge 424
Ann Arbor 369
Boardman 367
Bologna 296
Nanjing 208
Westminster 202
Jacksonville 190
Lomé 178
Padova 171
Berlin 149
New York 142
Helsinki 134
Jinan 121
San Diego 119
Menlo Park 112
Beijing 108
Medford 99
Amman 96
Saint Petersburg 96
Redmond 88
Shenyang 85
Sofia 85
Abidjan 80
Hebei 77
Turin 68
Changsha 67
Milan 66
Florence 65
Nanchang 62
Jakarta 59
Mülheim 57
Guangzhou 49
Jiaxing 48
Brussels 47
Shanghai 47
Abeokuta 45
Des Moines 41
Tianjin 40
Zhengzhou 40
Los Angeles 39
Redwood City 37
Dearborn 35
Hangzhou 35
Olalla 34
Rome 34
Toronto 34
Norwalk 32
Kuban 31
Pune 31
Vienna 31
Bremen 30
Bühl 29
Fremont 27
London 27
Taizhou 27
Frankfurt am Main 26
Mahé 25
Haikou 24
Kunming 24
Ningbo 22
Paris 21
Lanzhou 20
Chicago 19
Falls Church 19
Moscow 19
Mountain View 19
Taiyuan 19
Tokyo 18
Wuhan 18
Fuzhou 17
San Francisco 17
Hyderabad 16
Phoenix 15
Monmouth Junction 14
São Paulo 14
Harbin 13
Hefei 13
Lappeenranta 13
Shenzhen 13
Verona 13
Xi'an 13
San Venanzo 12
Chengdu 11
Qingdao 11
Boydton 10
Washington 10
Totale 17.772
Salva come PNG Salva come JPEG
Nome #
Asbestos: a hidden player behind the cholangiocarcinoma increase? Findings from a case–control analysis 339
Adjuvant treatment in biliary tract cancer 211
A phase I study of continuous hepatic arterial infusion of Irinotecan in patients with locally advanced hepatocellular carcinoma. 197
Circadian variations of rectal cell proliferation in patients affected by advanced colorectal cancer. 195
Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastases. 194
Adjuvant chemotherapy for resected colorectal cancer metastases: literature revision and meta-analysis 194
Antitumoral efficacy of the protease inhibitor gabexate mesilate in colon cancer cells harbouring KRAS, BRAF and PIK3CA mutations 186
Antiprotease strategy in combination with gemcitabine as a putative novel therapeutic approach for pancreatic cancer treatment 183
219 MiR-21 expression correlates with prognosis in extrahepatic radically resected cholangiocarcinomas treated with gemcitabine-based adjuvant chemotherapy 175
Antiprotease strategy in pancreatic cancer treatment: emergence from a preclinical study. 173
An atlas for clinical target volume definition, including elective nodal irradiation in definitive radiotherapy of biliary cancer 172
Brain Metastases from Biliary Tract Cancer: A Monocentric Retrospective Analysis of 450 Patients 171
Chemotherapy followed by chemoradiotherapy in locally advanced pancreatic cancer:A literature review and report of two cases 169
Antitumoral Efficacy of Two Turmeric Extracts According to Different Extraction Methods in Hepatocellular Carcinoma Cell Lines 166
null 164
Specific Toxicity of Maintenance Olaparib Versus Placebo in Advanced Malignancies: A Systematic Review and Meta-analysis 163
Fulminant hepatitis in a patient with hepatocellular carcinoma related to nonalcoholic steatohepatitis treated with sorafenib. 162
Combined low densities of FoxP3+ and CD3+ tumor-infiltrating lymphocytes identify stage II colorectal cancer at high risk of progression 162
An astonishing case of liver-only metastatic colorectal cancer cured by FOLFOXIRI alone 160
Complete remission of primary colon cancer in a metastatic patient treated with CPT-11 plus capecitabine. 159
Changes in the surgical approach to hilar cholangiocarcinoma during an 18-year period in a Western single center 159
Aspirin for cholangiocarcinoma prevention: New targets to shift the dogma from ascertained risk to possible prevention 154
Cell proliferation and ultrastructural changes of the duodenal mucosa of patients affected by familial adenomatous polyposis. 153
SUSTAINED COMPLETE RESPONSE OF ADVANCED HEPATOCELLULAR CARCINOMA WITH METRONOMIC CAPECITABINE: A REPORT OF THREE CASES 150
Genome-wide analysis identifies MEN1 and MAX mutations and a neuroendocrine-like molecular heterogeneity in Quadruple WT GIST 150
HIV enteropathy: undescribed ultrastructural changes of duodenal mucosa and their regression after triple antiviral therapy. A case report 149
ACTIVATED NF-KB IN COLORECTAL CANCER: PREDICTIVE OR PROGNOSTIC FACTOR? 149
Can the tyrosine kinase inhibitors trigger metabolic encephalopathy in cirrhotic patients? 148
Clinical Target Volume in Biliary Carcinoma: A Systematic Review of Pathological Studies. 148
Asbestos: a putative risk factor for intrahepatic cholangiocarcinoma 147
Membrane human equilibrative nucleoside transporter 1 is associated with a high proliferation rate and worse survival in resected intrahepatic cholangiocarcinoma patients not receiving adjuvant treatments 146
Molecular imaging and targeted therapies in oncology: new concepts in treatment response assessment. a collection of cases. 145
Membrane localization of human equilibrative nucleoside transporter 1 in tumor cells may predict response to adjuvant gemcitabine in resected cholangiocarcinoma patients 144
Risk of duodenal adenomas in familial adenomatous polyposis to progress toward advanced neoplastic disease 143
Integrated genomic study of quadruple-WT GIST (KIT/PDGFRA/SDH/RAS pathway wild-type GIST) 143
Cholangiocarcinoma: From risk to prevention? 143
Whole exome sequencing (WES) on formalin-fixed, paraffin-embedded (FFPE) tumor tissue in gastrointestinal stromal tumors (GIST) 142
null 142
Venous thromboembolism and port-related thrombosis in metastatic colorectal cancer patients: a monocenter experience. 140
Yttrium-90 radioembolization for unresectable/recurrent intrahepatic cholangiocarcinoma: a survival, efficacy and safety study 135
Metronomic capecitabine vs. best supportive care in Child-Pugh B hepatocellular carcinoma: A proof of concept 135
An exploratory study by DMET array identifies a germline signature associated with imatinib response in gastrointestinal stromal tumor 135
Surveillance for Hepatocellular Carcinoma Also Improves Survival of Incidentally Detected Intrahepatic Cholangiocarcinoma Arisen in Liver Cirrhosis 135
Molecular imaging suggests efficacy of bevacizumab beyond the second line in advanced colorectal cancer patients. 133
Gene expression profiling of liver metastases from colorectal cancer as potential basis for treatment choice 133
Breast carcinoma presenting as linitis plastica 133
Genetic heterogeneity in cholangiocarcinoma: a major challenge for targeted therapies 133
Integrated Molecular Characterization of Gastrointestinal Stromal Tumors (GIST) Harboring the Rare D842V Mutation in PDGFRA Gene. 132
Bone metastases in biliary cancers: A multicenter retrospective survey 132
Dyskerin expression in human fetal, adult and neoplastic intrahepatic bile ducts: Correlations with cholangiocarcinoma aggressiveness 129
A multicenter survey on second-line chemotherapy for advanced biliary tract cancer 126
Effectiveness and cost-effectiveness of peri-operative versus post-operative chemotherapy for resectable colorectal liver metastases. 126
Occupational exposure to asbestos and risk of cholangiocarcinoma: a population-based case-control study in four Nordic countries 125
Treatment of colorectal cancer liver metastases 124
In Reply 124
Alpha-fetoprotein kinetics in patients with hepatocellular carcinoma receiving ramucirumab or placebo: An analysis of the phase 3 REACH study 124
Pancreatic mucinous cystadenocarcinoma in a patient harbouring BRCA1 germline mutation effectively treated with olaparib: A case report 124
BIFIDOBACTERIACEAE IN THE ACHLORIDRIC STOMACH 121
Efficacy of weekly docetaxel in locally advanced cardiac angiosarcoma 121
Genomic And Genetic Characterization of Cholangiocarcinoma Identifies Therapeutics Targets for Tyrosine Kinase Inhibitors 119
Intrahepatic cholangiocarcinoma: primary liver resection and aggressive multimodal treatment of recurrence significantly prolong survival. 119
Metronomic capecitabine as second-line treatment for hepatocellular carcinoma after sorafenib discontinuation. 119
Intestinal microflora and digestive toxicity of irinotecan in mice. 119
INTRAHEPATIC CHOLANGIOCARCINOMA DEVELOPMENT IN A PATIENT WITH A NOVEL BAP1 GERMLINE MUTATION AND LOW EXPOSURE TO ASBESTOS 118
Interactions between commensal bacteria and gut sensorimotor function in health and disease. 116
Urease-Positive Bacteria Other than Helicobacter pylori in Human Gastric Juice and Mucosa 116
Second surgery or chemotherapy for relapse after radical resection of colorectal cancer metastases. 116
Estimation of the Survival Benefit Obtainable From Screening for the Early Detection of Pancreatic Cancer 116
Postsorafenib systemic treatments for hepatocellular carcinoma: Questions and opportunities after the regorafenib trial 116
Heterotopic segmental liver transplantation on splenic vessels after splenectomy with delayed native hepatectomy after graft regeneration: A new technique to enhance liver transplantation 116
High prevalence of asbestos exposure in bile duct cancer patients 115
Re: Effect of simvastatin on cetuximab resistance in human colorectal cancer with KRAS mutations. 114
Capecitabine(CAP) based regimens vs infusional 5FU/AF in metastatic colorectal cancer cost/effectivness: the differences across the atlantic ocean 113
Multivariate prognostic factors analysis for second-line chemotherapy in advanced biliary tract cancer. 113
Impact of surgery on the development of duodenal cancer in patients with familial adenomatous polyposis. 113
Impact of adjuvant chemotherapy on time to relapse in cholangiocarcinoma. 111
EXPOSURE TO ASBESTOS: A PUTATIVE UNKNOWN RISK FACTOR FOR INTRAHEPATIC CHOLANGIOCARCINOMA 111
Challenges in Repurposing Drugs in COVID-19 Pandemic. Debating on Potential New Refinements 111
Metronomic capecitabine in advanced hepatocellular carcinoma patients:a phase II study. 110
Cholangiocarcinoma: Current opinion on clinical practice diagnostic and therapeutic algorithms. A review of the literature and a long-standing experience of a referral center 110
Adjuvant Treatment and Follow-up Strategies 109
Bifidobacteria: microbiological aspects and probiotic potentialities 109
The role of metronomic capecitabine for treatment of recurrent hepatocellular carcinoma after liver transplantation 109
Metastatic pancreatic cancer: is gemcitabine still the best standard treatment? 108
Clinical safety and efficacy of adjuvant chemotherapy in radically resected cholangiocarcinoma patients. 108
Effect of the serine proteases inhibitor gabexate mesylate (GM) on the activity of gemcitabine (G) in cell lines of pancreatic cancer (PC) 108
Irinotecan toxicity: genes or intestinal microflora? 107
Port-a-Cath-related complications in 252 patients with solid tissue tumours and the first report of heparin-induced delayed hypersensitivity after Port-a-Cath heparinisation. 107
Chemotherapy in Patients with Advanced Cholangiocarcinoma 107
Good performance of platinum-based chemotherapy for high-grade gastroenteropancreatic and unknown primary neuroendocrine neoplasms 107
KRAS and BRAF mutational status as selective criteria for targeted therapy in cholangiocarcinoma. 106
Radiotherapy in the management of gist: state of the art and new potential scenarios 106
Plasma membrane localization of human equilibrative nucleoside transporter 1 (hENT-1) to predict better outcome of adjuvant gemcitabine in cholangiocarcinoma (CC) patients. 106
Cholangiocarcinoma: Epidemiology and risk factors 105
Bifidobacteriaceae usually colonize human hypochloridric stomach 104
Extrahepatic Feeding of HCC Limits the Use of TACE? Evidences from Literature and Clinical Experience 104
EXOCRINE-ENDOCRINE PANCREATIC CANCER AND alpha-FETOPROTEIN 103
Surgical debulking of gastrointestinal stromal tumors: is it a reasonable option after second-line treatment with sunitinib? 103
Radiotherapy or chemoradiation in unresectable biliary cancer: A retrospective study 103
Durable Complete Response to Frontline Docetaxel in an Advanced Prostate Cancer Patient with Favourable CYP1B1 Isoforms: Suggestion for Changing Paradigms? 102
Totale 13.602
Salva come PNG Salva come JPEG
Categoria #
all - tutte 80.433
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.433
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.767 0 0 0 0 0 0 596 661 645 354 208 303
2020/20213.540 632 195 93 106 80 189 91 160 356 141 157 1.340
2021/20225.060 418 190 243 327 379 227 167 286 483 313 1.168 859
2022/20236.072 659 808 312 673 401 445 192 349 979 214 423 617
2023/20241.591 194 268 113 136 113 331 73 83 51 103 58 68
2024/20253.790 253 1.041 643 502 1.034 304 13 0 0 0 0 0
Totale 26.885